ArticleScientific reports2020

The HSP90 inhibitor Onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: an in vitro and in vivo approach.

Diana Spiegelberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.